C=o Other Than As Ketone Or Aldehyde Patents (Class 514/521)
  • Patent number: 9611404
    Abstract: A method of making a sacrificial coating composition is disclosed. The method comprises emulsifying an oil with surfactant to form an oil-in-water emulsion; and combining ingredients comprising (i) at least one polymer, (ii) at least one hygroscopic material, (iii) the oil-in water emulsion and (iv) water to produce the sacrificial coating composition. The at least one polymer is selected from the group consisting of a hydrophilic polymer, a latex comprising polymer particles dispersed in a continuous liquid phase, or mixtures thereof.
    Type: Grant
    Filed: September 23, 2014
    Date of Patent: April 4, 2017
    Assignee: XEROX CORPORATION
    Inventors: Gordon Sisler, Guiqin Song, Brynn Dooley, Marcel P. Breton, Suxia Yang
  • Patent number: 9572346
    Abstract: The invention relates to an octanoic, nonanoic and decanoic (C8, 9, 10) fatty acids mixture with a pyrethroid. The invention also relates to methods of using the octanoic, nonanoic and decanoic (C8, 9, 10) fatty acids and pyrethroid mixture to achieve superior arthropod control.
    Type: Grant
    Filed: October 2, 2014
    Date of Patent: February 21, 2017
    Assignee: Valent BioSciences Corporation
    Inventors: Benjamin A. Belkind, Jason Clark, Peter DeChant
  • Patent number: 9309378
    Abstract: A polyacrylamide-based composition as a microemulsion is provided in the form of a water-in-oil microemulsion with polyacrylamide dissolved in the water phase, and further comprising ethylene oxide-propylene oxide block copolymer. Specifically, the present invention includes, dissolved in the water phase, a polyacrylamide copolymer and an EO/PO block copolymer, with the water phase mixed with an oil phase. Preferably, the present invention may further comprise the presence of at least one fatty acid and/or at least one nonionic surfactant to stabilize the microemulsion. In addition, the present invention may further comprise effective amount of other components, such as pesticides and/or fertilizers, that may be delivered to trees, plants or other vegetation.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: April 12, 2016
    Assignee: Exacto, Inc.
    Inventors: Franklin E. Sexton, Todd J. O'Connell, Ryan T. Strash
  • Patent number: 9290445
    Abstract: Methods of synthesizing a levodopa ester prodrug, salts thereof, and synthetic intermediates thereof are disclosed.
    Type: Grant
    Filed: October 19, 2009
    Date of Patent: March 22, 2016
    Assignee: XenoPort, Inc.
    Inventors: Stephen P. Raillard, Adam Mann, Suresh K. Manthati, Randall A. Scheuerman, Tono Estrada, Mark Q. Nguyen, Cindy X Zhou
  • Patent number: 9226507
    Abstract: The current invention provides a kit of parts for producing an emulsifiable pesticide solution comprising: (a) a water miscible organic solvent selected from the list of a glycol ether, a glycerol formal, dimethylsulfoxide, gamma-butyrolactone or mixtures thereof, (b) an alkoxylated alcohol with an average of 6 to 80 moles of ethylene oxide and 2 to 60 moles of propylene oxide per mole of alcohol; and (c) a pesticidal active ingredient. The invention further provides a composition for producing an emulsifiable pesticide solution, a method for producing such a composition and a method for treating an agricultural crop. In addition the invention provides some advantageous pesticidal compositions.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: January 5, 2016
    Inventor: Alan Pirotte
  • Patent number: 9204630
    Abstract: An encapsulated composition of (a) a pesticide at least active via ingestion that is photolabile, and (b) at least one photoprotectant, wherein the encapsulating polymeric barrier is base triggerable is disclosed. A method for controlling damage of a material by a pest by the use of such encapsulated compositions is likewise disclosed. The composition as disclosed gives protection for beneficial arthropods and reduces workers exposure.
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: December 8, 2015
    Assignee: Syngenta Participations AG
    Inventors: Ian Malcolm Shirley, Tanya Wright, Robert Michael Perrin, Patrick Mulqueen, Anne Waller, Andy Pierce
  • Patent number: 9149416
    Abstract: The present invention provides an insecticidal emulsion cleansing system comprising a clear oil-in-water (o/w) emulsion wherein the oil phase contains an ionic surfactant and an insecticide suspended together as nanometer sized particles in the water phase; and wherein the water phase contains an oppositely charged polymer. The insecticide is preferably a pyrethroid such as a natural pyrethrin or a synthetic pyrethroid. Suitable pyrethroids include pyrethroid esters and pyrethroid ethers.
    Type: Grant
    Filed: August 21, 2009
    Date of Patent: October 6, 2015
    Assignee: WELLMARK INTERNATIONAL
    Inventors: Min Xie, Robin Rudolph, Stephanie Ponder
  • Patent number: 9139430
    Abstract: Composite nanogranules from polymer/inorganic nanoparticle, especially first composite nanogranules which are formed from first polymer and inorganic nanoparticles, second composite nanogranules which are obtained by forming second polymer on the first composite nanogranules, third composite nanogranules which is obtained by forming third polymer on the second composite nanogranules, and Nth composite nanogranules which is obtained by forming Nth polymer on the (N?1)th composite nanogranules with the similar method, are disclosed. A composition comprising anyone of the composite nanogranules described above is disclosed. The preparation method thereof and use of the same are also disclosed.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: September 22, 2015
    Assignee: Wuxi Now Materials Corp.
    Inventors: Suping Qian, Yuhong Xu, Zhentian Fan, Yongtai Hou
  • Patent number: 9040577
    Abstract: Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone, or pharmaceutically acceptable salts thereof, wherein said composition is administered substantially continuously, and compositions that can be used in the disclosed methods.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: May 26, 2015
    Assignee: NeuroDerm, Ltd.
    Inventors: Oron Yacoby-Zeevi, Mara Nemas
  • Patent number: 9040578
    Abstract: Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone, or pharmaceutically acceptable salts thereof, wherein said composition is administered substantially continuously, and compositions that can be used in the disclosed methods.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: May 26, 2015
    Assignee: NeuroDerm, Ltd.
    Inventors: Oron Yacoby-Zeevi, Mara Nemas
  • Publication number: 20150140056
    Abstract: The present disclosure relates to water dispersible granular pesticide compositions, and methods of making and using the compositions. The pesticide compositions include an inner layer including a first pesticide coated on to a substrate, and an outer layer comprising a second pesticide coated on the inner layer. The outer layer increases the water dispersibility of the granular composition, and protects the first pesticide against hydrolysis and photolysis.
    Type: Application
    Filed: January 23, 2015
    Publication date: May 21, 2015
    Inventors: Victor F. Man, Yvonne M. Killeen, Susan M. Viall
  • Publication number: 20150132260
    Abstract: The present invention relates to the use of the measure of anelloviral load for the determination of immunosuppression. More precisely, the present invention provides a method for characterizing the immunosuppressed or non-immunosuppressed status of a subject, comprising the steps of determining the anelloviral load from a biological sample of the said subject, and determining from the said comparison the immunosuppressed or non-immunosuppressed status. The determination of the immunosuppressed status of the subject can then be used to design or adapt a therapeutic treatment.
    Type: Application
    Filed: April 19, 2013
    Publication date: May 14, 2015
    Inventors: Marc Eloit, Justine Cheval, Charles Hebert, Marc Lecuit
  • Publication number: 20150126591
    Abstract: The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of Parkinson's disease may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be also used for the treatment of Huntington's disease, Alzheimer's disease, Multiple Sclerosis, Lateral Sclerosis, Neural Motor disorders.
    Type: Application
    Filed: March 21, 2013
    Publication date: May 7, 2015
    Inventor: Mahesh Kandula
  • Patent number: 9011889
    Abstract: The present invention relates to an insecticide-containing polymeric material containing at least one embedded insecticidally active ingredient in the polymeric matrix and having excellent biological activity, and also to the products produced from this polymer and to their use for protecting humans, animals and plants against arthropods, particularly for controlling insects.
    Type: Grant
    Filed: April 14, 2011
    Date of Patent: April 21, 2015
    Assignee: Bayer CropScience AG
    Inventors: Maren Heinemann, Thomas Böcker, Karin Horn, Guenther Nentwig, Rainer Sonneck, Thomas König
  • Publication number: 20150104417
    Abstract: The present invention relates to a composition comprising at least one biological control agent. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts.
    Type: Application
    Filed: May 29, 2013
    Publication date: April 16, 2015
    Inventors: Elke Hellwege, Wolfram Andersch, Klaus Stenzel, Bernd Springer
  • Publication number: 20150094343
    Abstract: The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as inhibitors of Jak2/STAT3 pathways and downstream targets and inhibit the growth and survival of cancerous cell lines.
    Type: Application
    Filed: June 4, 2014
    Publication date: April 2, 2015
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Waldemar PRIEBE, Izabela FOKT, Slawomir SZYMANSKI, Timothy MADDEN, Jeffrey MYERS, Charles CONRAD
  • Publication number: 20150087517
    Abstract: The present disclosure relates to the manufacturing of specifically targeting microcapsules comprising agrochemicals. More specifically, the disclosure relates to specifically targeting microcapsules, to which targeting agents are covalently linked at a ratio from about 0.01 ?g-to about 1 ?g targeting agents per square centimeter of the surface of the microcapsule, such that the microcapsules are capable of binding the agrochemicals contained in the microcapsules to a surface, and to agrochemical compositions comprising such microcapsules.
    Type: Application
    Filed: October 8, 2012
    Publication date: March 26, 2015
    Inventors: Peter Verheesen, Chris De Jonghe
  • Patent number: 8975292
    Abstract: The present invention relates to a method for controlling arthropods comprising the application of an aqueous gel which contains an insecticide, an attractant and a thickener, wherein the aqueous gel is applied in the form of spots on fruit trees. The invention further relates to an aqueous gel comprising an insecticide, an attractant, a thickener, a humectant and a feeding stimulant. The invention also relates to a concentrated gel for preparing the aqueous gel.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: March 10, 2015
    Assignee: BASF SE
    Inventors: Claude Taranta, Tatjana Levy, Ouidad Benlahmar, Marc Nolte, Thomas Kröhl, Christoph Randt, Thomas Bork, Wolfgang Meier, Clark D. Klein, Tiffany Hennessey
  • Patent number: 8975296
    Abstract: The instant invention relates to pharmaceutical compositions containing cathespin K inhibitors. Also disclosed are processes for making said pharmaceutical compositions.
    Type: Grant
    Filed: March 20, 2013
    Date of Patent: March 10, 2015
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Haihong Fan, Majid Mahjour, Justin Moser, Bhagwant Rege
  • Publication number: 20150065475
    Abstract: Oil-in-water fungicidal formulations are prepared having pigment dispersed therein, the pigment being stable within the oil-in-water emulsion as a result of the addition of suitable silicone surfactants and suitable emulsifiers. The formulations can be prepared either as a 2-pack formulation or as a single formulation. In the case of the single formulation polyethylene glycol is also added. In either case, the formulations show a synergistic effect through the addition of the pigment, the resulting formulations having an increased efficacy. Further, the formulations show a synergistic effect when mixed with conventional chemical fungicides, both being added in reduced amounts compared to recommended rates.
    Type: Application
    Filed: September 9, 2014
    Publication date: March 5, 2015
    Inventors: Michael Fefer, Jun Liu, Tomoki Ruo, Sonia Edith Hevia
  • Publication number: 20150056257
    Abstract: The present invention relates to a method for preparing an emulsifiable granule comprising the steps of a) emulsifying water with a solution of a pesticide in a water-insoluble solvent, b) contacting the emulsion resulting from step a) and a solid dispersant containing a water-soluble polycarboxylate and a water-soluble anionic surfactant, and c) extruding the paste resulting from step b). The invention further relates to emulsifiable granules containing a water-insoluble solvent, a pesticide, which is dissolved in the water-insoluble solvent, a water-soluble polycarboxylate, and a water-soluble anionic surfactant.
    Type: Application
    Filed: February 26, 2013
    Publication date: February 26, 2015
    Inventors: Claude Taranta, Thomas Bork, Jochen Schreieck, Helmut Mueller, Nadine Riediger, Clark D. Klein, Rebecca Willis, Tatjana Sikuljak, Simon Nord
  • Patent number: 8962681
    Abstract: The present invention relates to a method of treating a parasitic infection in an animal, particularly a filarial endoparasitic infection, comprising administering an effective amount of a Formula (I) compound or a Formula (II) compound stereoisomer thereof, or veterinarily acceptable salt of said compound or stereoisomer thereof, or in combination with at least one additional veterinary agent, wherein: R1, R2, R3, R4, R5, R1a, R1b, R1c, R1d, R1e are as described herein.
    Type: Grant
    Filed: October 8, 2012
    Date of Patent: February 24, 2015
    Assignee: Zoetis LLC
    Inventors: George Anthony Conder, Kevin Evans, Patrick F. M. Meeus, Debra Jean Woods
  • Patent number: 8957098
    Abstract: The invention relates to the use of polycycloolefins in electronic devices and more specifically to the use of such polycycloolefins as interlayers applied to insulating layers used in electronic devices, the electronic devices that encompass such polycycloolefin interlayers and processes for preparing such polycycloolefin interlayers and electronic devices.
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: February 17, 2015
    Assignee: ALGIAX Pharmaceuticals GmbH
    Inventors: Guido Koopmans, Birgit Hasse, Stefan Mullner
  • Publication number: 20150045358
    Abstract: A pharmaceutical composition for treating disorders associated with insulin resistance is disclosed, and the composition comprises at least one inhibitor which is an effective agent to suppress endothelin-1-stimulated resistin gene expression through decreasing the endothelin-1-stimulated phosphorylation of proteins downstream of endothelin type A receptor, wherein the downstream signaling molecules comprise ERK1/2, JNKs, AKT, and STAT3 proteins, and wherein the inhibitor is selected from at least one antagonist of the endothelin type A receptor or downstream signaling proteins.
    Type: Application
    Filed: May 21, 2013
    Publication date: February 12, 2015
    Inventors: Yung-hsi KAO, Ya-chu Tang, Hsin-huei Chang, Hui-chen Ku
  • Publication number: 20150044149
    Abstract: The present disclosure relates, according to some embodiments, to molecules, including substituted propenoic amides (e.g., aryl substituted propenoic amides), that may receive excited state energy from light-absorbing molecules. According to some embodiments, the present disclosure relates to molecules, including substituted propenoic amides (e.g., aryl substituted propenoic amides), that may quench, dissipate, and/or otherwise resolve excited state energy (e.g., as heat).
    Type: Application
    Filed: August 5, 2014
    Publication date: February 12, 2015
    Inventors: Craig Bonda, Shengkui Hu, Gary A. Neudahl, Stephen O'Rourke, Stephen J. Semlow, Zhihui Zhang
  • Patent number: 8952031
    Abstract: The invention provides amino- and amido-aminotetralin compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, and n are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are antagonists at the mu opioid receptor. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat conditions associated with mu opioid receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: February 10, 2015
    Assignee: Theravance Biopharma R&D IP, LLC
    Inventors: Sean G. Trapp, Michael R. Leadbetter, Daniel D. Long, Lan Jiang, Sabine Axt
  • Publication number: 20150038466
    Abstract: The present invention relates to the use of compounds for the treatment or prevention of pain in mammals, in particularly in human beings, and also to a process for preparing these compounds.
    Type: Application
    Filed: December 31, 2012
    Publication date: February 5, 2015
    Inventors: Sylvie Ducki, Khalil Bennis, Alain Eschalier, Jérôme Busserolles, Florian Lesage, Nuno Rodriguez, Delphine Vivier
  • Publication number: 20150025042
    Abstract: Disclosed are compounds of formulae (I), (III), (IV), (VII), (X), (XI), (XII), (XIII) and (XIV), wherein the variables are as defined in the claims, and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: December 16, 2013
    Publication date: January 22, 2015
    Applicant: SYNTA PHARMACEUTICALS CORP.
    Inventors: Shoujun Chen, Keizo Koya, Zachary Demko, Lijun Sun
  • Publication number: 20150005356
    Abstract: This invention relates to pharmaceutical compositions of epinephrine for delivery to the nasal mucosa and methods of treating a subject in acute severe anaphylaxis, bronchospasm or during cardiopulmonary resuscitation (CPR). The composition further comprising agents, that either prevent localized degradation of epinephrine or enhance its absorption in the nasal mucosa to counter anaphylactic effects, symptoms or complications in a subject.
    Type: Application
    Filed: June 27, 2013
    Publication date: January 1, 2015
    Applicant: G2B PHARMA INC.
    Inventor: Nigel Ten Fleming
  • Patent number: 8921320
    Abstract: A targeted osmotic lysis (TOL) of tumor cells that over-express voltage-gated sodium channels (VGSCs) has been developed that uses a combined therapy of a drug that blocks sodium, potassium-adenosine triphosphatase (Na+, K+-ATPase) that is then followed by an activation of VGSCs, for example, by electrical or pharmacological stimulation. Activation of VGSCs conducts sodium into the cancer cells in much greater amounts than non-cancer cells. Water follows this sodium gradient into the cancer cells, causing swelling and lysis. Because non-cancerous cells do not over-express VGSCs, less sodium and less water will enter the cells, and the non-cancerous cells will not lyse. This method is applicable to all cells that over-express VGSCs, including, but not limited to, highly invasive breast cancer, prostate cancer, small cell lung cancer, non-small cell lung carcinoma, lymphoma, mesothelioma, neuroblastoma, and cervical cancer.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: December 30, 2014
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Dennis J. Paul, Harry J. Gould
  • Patent number: 8920846
    Abstract: A microcapsule in which a liquid droplet is coated with a resin, wherein in the droplet, a pesticidally active solid ingredient is suspended in a compound of formula (I), wherein R represents a C1-C5 alkyl group, is useful as a formulation of a pesticidally active solid ingredient.
    Type: Grant
    Filed: September 2, 2010
    Date of Patent: December 30, 2014
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Naoki Tsuda, Mayuko Ozawa
  • Patent number: 8906398
    Abstract: The present invention relates to an insecticide-containing fabric containing at least one embedded insecticidally active ingredient in the polymeric matrix and having excellent wash resistance, and also to the products produced from this fabric and to their use for protecting humans, animals and plants against arthropods, particularly for controlling insects.
    Type: Grant
    Filed: April 14, 2011
    Date of Patent: December 9, 2014
    Assignee: Bayer CropScience AG
    Inventors: Rainer Sonneck, Thomas Böcker, Karin Horn, Guenther Nentwig, Maren Heinemann, Thomas König
  • Publication number: 20140329901
    Abstract: The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as kinase inhibitors, cause the downregulation of c-myc, and inhibit the growth and survival of cancerous cell lines.
    Type: Application
    Filed: January 3, 2014
    Publication date: November 6, 2014
    Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Waldemar PRIEBE, Nicholas DONATO, Moshe TALPAZ, Slawomir SZYMANSKI, Izabela FOKT, Alexander LEVITZKI
  • Patent number: 8871806
    Abstract: Methods for reducing the incidence of flea allergy dermatitis (FAD) in a companion animal are disclosed, the methods directed to inhibiting blood feeding by ectoparasites on a companion animal. The methods of the present invention involve administering a pesticide composition comprising cyphenothrin to a companion animal, specifically dogs and cats, in doses and proportions which are parasiticidally effective against a variety of ectoparasites, and in formulations which are convenient for topical application to the animal's skin, preferably localized over a small surface area. Such methods are useful in preventing and/or reducing the incidence of flea allergy dermatitis.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: October 28, 2014
    Assignee: Sergeant's Pet Care Products, Inc.
    Inventor: Larry Nouvel
  • Patent number: 8871679
    Abstract: Fungicidal mixtures, comprising as active components 1) at least one 1-methylpyrazol-4-ylcarboxanilide of the formula I where R1?C1-C4-alkyl or C1-C4-haloalkyl, R2=hydrogen or halogen, X=hydrogen or halogen, Q=direct bond, a cyclopropylene or an anellated bicyclo[2.2.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: October 28, 2014
    Assignee: BASF SE
    Inventors: Markus Gewehr, Ulf Groeger, Egon Haden, Michael Vonend
  • Publication number: 20140315998
    Abstract: A pest control composition is provided having an excellent control effect on pests and containing an ester compound represented by the following formula (1) and diethyl adipate. A method is also provided for controlling pests including applying the pest control composition to pests or habitats of pests.
    Type: Application
    Filed: December 12, 2012
    Publication date: October 23, 2014
    Inventor: Masahiro Yamada
  • Patent number: 8865736
    Abstract: Compounds of formula (I) have antibacterial activity: wherein R represents hydrogen or 1, 2 or 3 optional substituents; W is ?C(R1)—; R1 is hydrogen and R2 is hydrogen, methyl, or fluorine; or R1 and R2 taken together are —CH2—, —CH2CH2, —O—, or, in either orientation, —O—CH2— or —OCH2CH2—; and R3 is a radical of formula -(Alk1)m-(Z)p-(Alk2)n-Q.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: October 21, 2014
    Assignee: Biota Scientific Pty Ltd
    Inventors: David Ryall Brown, Ian Collins, Lloyd George Czaplewski, David John Haydon
  • Patent number: 8853266
    Abstract: This invention provides use of a SARM compound or a composition comprising the same in treating a variety of diseases or conditions in a subject, including, inter-alia, a diabetes disease, and/or disorder such as cardiovascular disease, atherosclerosis, cerebrovascular conditions, diabetic nephropathy, diabetic neuropathy and diabetic retinopathy.
    Type: Grant
    Filed: April 13, 2007
    Date of Patent: October 7, 2014
    Assignee: University of Tennessee Research Foundation
    Inventors: James T. Dalton, Duane D. Miller
  • Publication number: 20140296335
    Abstract: The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow. The invention also relates to pharmaceutical compositions formulated for use in such methods and to kits for such methods.
    Type: Application
    Filed: June 16, 2014
    Publication date: October 2, 2014
    Inventors: Martin P. MAGUIRE, Elise Rioux, Harry J. Leighton
  • Publication number: 20140294968
    Abstract: The invention relates to novel polyacrylate-based active compound-comprising particles which bind to hair, and to the use of these particles for preparing medicaments, in particular for veterinary medicine. The particles comprise uncharged and cationic polyacrylate and are at most 10 um big.
    Type: Application
    Filed: July 23, 2012
    Publication date: October 2, 2014
    Applicant: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Stefan Hofmann, Claudia Selbach, Eva Maria Krüdewagen, Dorothee Stanneck
  • Publication number: 20140296297
    Abstract: The present invention concerns polymeric material containing at least an embedded insecticidally active ingredient and an additive, which are released at room temperature. It similarly concerns materials produced from this polymer, for example in the form of self-supporting film/sheet, threads, wovens, fabrics, textiles, nets, curtains and pellets. The invention further concerns processes for producing such polymeric material and also the use of the self-supporting film/sheet, threads, wovens, fabrics, textiles and nets and curtains produced from the material for protecting humans, animals and plants and buildings, machines and packaging against arthropods, particularly for controlling insects.
    Type: Application
    Filed: June 9, 2014
    Publication date: October 2, 2014
    Inventors: Rainer SONNECK, Thomas BÖCKER, Karin HORN, Guenther NENTWIG, Maren HEINEMANN, Thomas KÖNIG
  • Patent number: 8846732
    Abstract: Biogenic sulfide production is synergistically inhibited by treating sulfate-reducing bacteria (SRB) with a biocide and a metabolic inhibitor. The biocide directly kills a first portion of the SRB. The metabolic inhibitor inhibits sulfate-reducing growth of a second portion of the SRB without directly killing the second portion of the SRB. The treatment of SRB with both a biocide and a metabolic inhibitor provides effective biogenic sulfide inhibition at significantly lower concentrations than would be required if the biocide or metabolic inhibitor was used alone.
    Type: Grant
    Filed: October 6, 2010
    Date of Patent: September 30, 2014
    Assignees: ConocoPhillips Company, University Technologies International, Inc.
    Inventors: Gary E. Jenneman, Anne Greene, Gerrit Voordouw
  • Publication number: 20140287010
    Abstract: The present invention provides a composition including a polymer nanoparticle and at least one agricultural active compound incorporated with the nanoparticle, wherein the nanoparticle are less than 100 nm in diameter, and the polymer includes a polyelectrolyte.
    Type: Application
    Filed: May 30, 2014
    Publication date: September 25, 2014
    Applicant: Vive Crop Protection Inc.
    Inventors: Fugang Li, Hung Pham, Darren J. Anderson
  • Publication number: 20140287920
    Abstract: A water dispersible granule composition comprising microcapsules comprising at least one agrochemical active ingredient encapsulated within a urea formaldehyde polymeric shell wall, at least one inert filler and at least one agrochemical excipients.
    Type: Application
    Filed: November 2, 2012
    Publication date: September 25, 2014
    Inventor: Deepak Pranjivandas Shah
  • Patent number: 8828906
    Abstract: The present invention relates to novel active compound combinations comprising, firstly, at least one known compound of the formula (I) in which R1 and A have the meanings given in the description and, secondly, at least one further known active compound from the class of the pyrethroids, which combinations are highly suitable for controlling animal pests such as insects and unwanted acarids.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: September 9, 2014
    Assignee: Bayer CropScience AG
    Inventors: Heike Hungenberg, Peter Jeschke, Robert Velten, Wolfgang Thielert
  • Publication number: 20140243408
    Abstract: The present invention relates to a method of treating a parasitic infection in an animal, particularly a filarial endoparasitic infection, comprising administering an effective amount of a Formula (I) compound or a Formula (II) compound stereoisomer thereof, or veterinarily acceptable salt of said compound or stereoisomer thereof, or in combination with at least one additional veterinary agent, wherein: R1, R2, R3, R4, R5, R1a, R1b, R1c, R1d, R1e are as described herein.
    Type: Application
    Filed: October 8, 2012
    Publication date: August 28, 2014
    Inventors: George Anthony Conder, Kevin Evans, Patrick F. M. Meeus, Debra Jean Woods
  • Patent number: 8815269
    Abstract: The present invention relates to compositions for the control of pests, in particular insecticidal suspension concentrates and spray solutions made from them, to processes for their preparation, and to the use of such formulations for the sustained control of animal pests (arthropods) on a variety of surfaces. The present invention furthermore relates to the use of certain polymer dispersions in pesticides, in particular to their use for extending the long-term activity of these compositions when they are applied to surfaces. The present invention furthermore relates to the use of the compositions according to the invention for controlling parasites, in particular ectoparasites, in animals.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: August 26, 2014
    Assignee: Bayer Cropscience AG
    Inventors: Johan Kijlstra, Frank Rosenfeldt, Guenther Nentwig, Volker Gutsmann, Rainer Sonneck, Douglas Ross
  • Publication number: 20140227354
    Abstract: The present invention relates to stable pharmaceutical compositions comprising entacapone, levodopa and carbidopa, or pharmaceutically acceptable salts or hydrates thereof. The invention also relates to processes for the preparation of such compositions.
    Type: Application
    Filed: April 15, 2014
    Publication date: August 14, 2014
    Applicant: WOCKHARDT RESEARCH CENTRE
    Inventors: Sudhir Goswami, Mahesh Rameshwar Kalantri, Asif Mohammad, Narayanan Murali, Girish Kumar Jain
  • Publication number: 20140221478
    Abstract: The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
    Type: Application
    Filed: April 7, 2014
    Publication date: August 7, 2014
    Applicant: ViroBay, Inc.
    Inventors: John O. Link, Craig J. Mossman, Jie Liu, Soon Hyung Woo
  • Publication number: 20140212466
    Abstract: The invention provides a method for the preparation of a carrier liquid which comprises the steps of: (I) preparing a single phase solution comprising: (a) a solvent or a mixture of miscible solvents, (b) a liquid carrier material, which is soluble in solvent (a), and (c) a dopant material which is also soluble in solvent (a); (II) cooling (preferably freezing) the single phase solution produced in step (I) to a temperature at which at least both the solvent (a) and carrier material (b) become solid; and (III) removing solid solvent (a) from the cooled (frozen) single phase solution in vapour form, such that the remaining cooled (frozen) carrier material (b) and dopant material (c) are returned to ambient temperature thus providing a product of liquid carrier material (b) having dopant material (c) dispersed therein.
    Type: Application
    Filed: August 20, 2012
    Publication date: July 31, 2014
    Applicant: IOTA NANOSOLUTIONS LIMITED
    Inventors: Alison Jayne Foster, James Long, Steven Paul Rannard, Dong Wang